121 related articles for article (PubMed ID: 10202665)
1. CD44 is a marker of endocervical neoplasia.
Ibrahim EM; Blackett AD; Tidy JA; Wells M
Int J Gynecol Pathol; 1999 Apr; 18(2):101-8. PubMed ID: 10202665
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
Saegusa M; Hashimura M; Machida D; Okayasu I
J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
[TBL] [Abstract][Full Text] [Related]
3. The expression of epithelial specific antigen in cervical intraepithelial neoplasia and adenocarcinoma.
Markaki S; Lazaris D; Papaspirou I; Paulou V
Eur J Gynaecol Oncol; 2004; 25(1):101-3. PubMed ID: 15053074
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.
Little L; Stewart CJ
Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
[TBL] [Abstract][Full Text] [Related]
7. The two faces of cervical adenocarcinoma in situ.
Smedts F; Ramaekers FC; Hopman AH
Int J Gynecol Pathol; 2010 Jul; 29(4):378-85. PubMed ID: 20567153
[TBL] [Abstract][Full Text] [Related]
8. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.
Smedts F; Ramaekers F; Leube RE; Keijser K; Link M; Vooijs P
Am J Pathol; 1993 Feb; 142(2):403-12. PubMed ID: 7679549
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium.
Stewart CJ; Little L
Pathology; 2010 Apr; 42(3):217-23. PubMed ID: 20350213
[TBL] [Abstract][Full Text] [Related]
10. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
12. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.
Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D
Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774
[TBL] [Abstract][Full Text] [Related]
13. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?
Park JJ; Sun D; Quade BJ; Flynn C; Sheets EE; Yang A; McKeon F; Crum CP
Am J Surg Pathol; 2000 Oct; 24(10):1414-9. PubMed ID: 11023104
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium.
Kohlberger PD; Kieback DG; Bancher D; Stickeler E; Heinzl H; Gitsch G; Breitenecker G; Kainz C
Gynecol Oncol; 1997 Aug; 66(2):227-32. PubMed ID: 9264567
[TBL] [Abstract][Full Text] [Related]
15. New developments in endocervical glandular lesions.
McCluggage WG
Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447
[TBL] [Abstract][Full Text] [Related]
16. BCL-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma.
Ter Harmsel B; Smedts F; Kuijpers J; Jeunink M; Trimbos B; Ramaekers F
J Pathol; 1996 May; 179(1):26-30. PubMed ID: 8691340
[TBL] [Abstract][Full Text] [Related]
17. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
18. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
19. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
20. Cd44: a marker of squamous differentiation in adenosquamous neoplasms.
Ylagan LR; Scholes J; Demopoulos R
Arch Pathol Lab Med; 2000 Feb; 124(2):212-5. PubMed ID: 10656728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
